CleanSpace Holdings Limited (CSX.AX)
AUD 0.42
(13.51%)
AUD 0.42
(13.51%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 26.05 Million AUD | -10.09% |
| 2023 | 28.97 Million AUD | -24.46% |
| 2022 | 38.35 Million AUD | -24.37% |
| 2021 | 50.71 Million AUD | 1.84% |
| 2020 | 49.8 Million AUD | 550.52% |
| 2019 | 7.65 Million AUD | -6.0% |
| 2018 | 8.14 Million AUD | 56.98% |
| 2017 | 5.18 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 27.47 Million AUD | -28.38% |
| 2024 Q4 | 26.05 Million AUD | 0.0% |
| 2024 FY | 26.05 Million AUD | -10.09% |
| 2024 Q3 | 26.05 Million AUD | -5.16% |
| 2024 Q2 | 27.47 Million AUD | 0.0% |
| 2023 Q4 | 38.35 Million AUD | 32.37% |
| 2023 Q2 | 32.93 Million AUD | 0.0% |
| 2023 FY | 28.97 Million AUD | -24.46% |
| 2023 Q1 | 32.93 Million AUD | -14.14% |
| 2023 Q3 | 28.97 Million AUD | -12.01% |
| 2022 Q4 | 38.35 Million AUD | 0.0% |
| 2022 Q3 | 38.35 Million AUD | -12.05% |
| 2022 Q2 | 43.6 Million AUD | 0.0% |
| 2022 Q1 | 43.6 Million AUD | -14.01% |
| 2022 FY | 38.35 Million AUD | -24.37% |
| 2021 Q1 | 60.19 Million AUD | 162.29% |
| 2021 FY | 50.71 Million AUD | 1.84% |
| 2021 Q2 | 60.19 Million AUD | 0.0% |
| 2021 Q4 | 50.71 Million AUD | 0.0% |
| 2021 Q3 | 50.71 Million AUD | -15.75% |
| 2020 Q1 | - AUD | 0.0% |
| 2020 Q3 | 22.95 Million AUD | 0.0% |
| 2020 Q4 | 22.95 Million AUD | 0.0% |
| 2020 FY | 49.8 Million AUD | 550.52% |
| 2019 FY | 7.65 Million AUD | -6.0% |
| 2018 FY | 8.14 Million AUD | 56.98% |
| 2017 FY | 5.18 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| 4DMedical Limited | 120.01 Million AUD | 78.293% |
| Adherium Limited | 9.88 Million AUD | -163.491% |
| Aroa Biosurgery Limited | 101.82 Million AUD | 74.414% |
| Atomo Diagnostics Limited | 11.37 Million AUD | -128.945% |
| Anteris Technologies Ltd | 45.7 Million AUD | 42.996% |
| Control Bionics Limited | 9.02 Million AUD | -188.588% |
| CardieX Limited | 12.64 Million AUD | -105.946% |
| Compumedics Limited | 40.35 Million AUD | 35.448% |
| Cochlear Limited | 2.74 Billion AUD | 99.051% |
| Cyclopharm Limited | 45.91 Million AUD | 43.26% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | -8.678% |
| Nova Eye Medical Limited | 29.88 Million AUD | 12.818% |
| HeraMED Limited | 2.95 Million AUD | -782.483% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | -113.959% |
| ImpediMed Limited | 46.98 Million AUD | 44.554% |
| InhaleRx Limited | 1.57 Million AUD | -1552.102% |
| LBT Innovations Limited | 7.93 Million AUD | -228.48% |
| Micro-X Limited | 26.89 Million AUD | 3.135% |
| Neurotech International Limited | 12.21 Million AUD | -113.305% |
| OncoSil Medical Limited | 6.71 Million AUD | -287.767% |
| PolyNovo Limited | 109.16 Million AUD | 76.136% |
| Respiri Limited | 6.19 Million AUD | -320.806% |
| SomnoMed Limited | 69.8 Million AUD | 62.679% |
| Universal Biosensors, Inc. | 30.12 Million AUD | 13.508% |
| Uscom Limited | 5.13 Million AUD | -407.374% |
| Visioneering Technologies, Inc. | 11.2 Million AUD | -132.493% |